Clinical Trials Directory

Trials / Unknown

UnknownNCT05362266

Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization

Incidence and Risk Factors of in Hospital Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization Treatment: a Retrospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.

Conditions

Timeline

Start date
2022-04-10
Primary completion
2023-03-01
Completion
2023-04-01
First posted
2022-05-05
Last updated
2022-05-05

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05362266. Inclusion in this directory is not an endorsement.

Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization (NCT05362266) · Clinical Trials Directory